Victor M Elner Selected Research

Absorbable Gelatin Sponge

11/2018

Socket Reconstruction With Bleomycin, Gentamicin, and Gelatin Sponges Following Eyelid-Sparing Orbital Exenteration for a Colobomatous Macrocyst in an Infant.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Victor M Elner Research Topics

Disease

12	Inflammation (Inflammations) 06/2022 - 01/2003
6	Macular Degeneration (Age-Related Maculopathy) 01/2018 - 01/2002
6	Graves Ophthalmopathy 05/2017 - 03/2010
5	Lymphoma (Lymphomas) 01/2020 - 01/2009
5	Optic Nerve Diseases (Optic Neuropathy) 05/2017 - 02/2008
5	Keratitis 04/2010 - 01/2003
4	Neoplasms (Cancer) 12/2019 - 05/2007
4	Retinal Diseases 01/2018 - 06/2004
3	Basal Cell Carcinoma (Rodent Ulcer) 01/2021 - 10/2013
3	Eye Diseases (Eye Disease) 08/2013 - 09/2004
3	Infections 06/2011 - 12/2006
2	Melanoma (Melanoma, Malignant) 12/2019 - 11/2016
2	Cicatrix (Scar) 11/2018 - 03/2009
2	Cysts 11/2018 - 03/2009
2	Diabetes Mellitus 01/2018 - 07/2008
2	Macular Edema 01/2018 - 05/2017
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 05/2017 - 05/2017
2	Disease Progression 05/2017 - 09/2007
2	Atrophy 01/2017 - 12/2013
2	Toxic Optic Neuropathy 01/2017 - 06/2011
2	Cataract (Cataracts) 05/2014 - 08/2013
2	Neoplasm Metastasis (Metastasis) 10/2013 - 01/2008
2	Fibrosis (Cirrhosis) 06/2013 - 08/2005
2	Mitochondrial Diseases (Mitochondrial Disease) 09/2012 - 10/2011
2	Exophthalmos (Proptosis) 11/2011 - 01/2011
2	Ischemia 01/2011 - 01/2003
2	Choroidal Neovascularization 05/2007 - 04/2002
2	Retinal Neovascularization 01/2005 - 01/2003
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Residual Neoplasm 12/2019
1	Pathologic Processes 01/2018
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2018
1	Relapsing-Remitting Multiple Sclerosis 05/2017
1	Multiple Sclerosis 05/2017
1	Dry Eye Syndromes (Dry Eye Syndrome) 05/2017
1	Graves Disease (Basedow Disease) 05/2017
1	Retinoblastoma (Glioblastoma, Retinal) 01/2017
1	Pupil Disorders (Marcus Gunn Pupil) 09/2015
1	Pathologic Dilatation (Ectasia) 01/2015
1	Edema (Dropsy) 01/2015
1	Foreign Bodies (Foreign Body) 01/2015
1	Keratoconus 01/2015
1	Pain (Aches) 01/2015
1	Photophobia (Light Sensitivity) 01/2015
1	Corneal Perforation 01/2015
1	Uveal melanoma 10/2013
1	Vascular Malformations 06/2013
1	Surgical Wound 06/2013
1	Myeloid Sarcoma (Chloroma) 05/2013
1	Hemangioma (Angioma) 09/2012
1	Granuloma 05/2012

Drug/Important Bio-Agent (IBA)

13	Retinaldehyde (Retinal)IBA 01/2018 - 05/2003
5	FlavoproteinsIBA 01/2018 - 02/2008
4	Rituximab (Mabthera)FDA Link 06/2022 - 01/2015
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2003
3	HhAntag691IBA 01/2021 - 10/2013
3	Proteins (Proteins, Gene)FDA Link 11/2016 - 01/2003
3	Biomarkers (Surrogate Marker)IBA 10/2013 - 01/2008
2	Bleomycin (Blenoxane)FDA LinkGeneric 11/2018 - 06/2013
2	Retinal Pigments (Pigments, Visual)IBA 01/2018 - 01/2011
2	CytokinesIBA 01/2018 - 04/2002
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2011 - 05/2009
2	Biological ProductsIBA 04/2010 - 05/2007
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2009 - 10/2007
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 07/2009 - 01/2008
2	HLA-DR Antigens (HLA-DR)IBA 07/2009 - 01/2008
2	Oxygen (Dioxygen)IBA 01/2005 - 09/2004
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2019
1	UbiquitinIBA 12/2019
1	Mitogen-Activated Protein KinasesIBA 12/2019
1	trametinibIBA 12/2019
1	dabrafenibIBA 12/2019
1	Pharmaceutical PreparationsIBA 01/2018
1	InflammasomesIBA 01/2018
1	AlarminsIBA 01/2018
1	CD40 Ligand (CD40L)IBA 01/2018
1	Fingolimod Hydrochloride (FTY720)FDA Link 05/2017
1	Melphalan (Alkeran)FDA LinkGeneric 01/2017
1	etoposide phosphate (Etopophos)FDA Link 01/2017
1	Carboplatin (JM8)FDA LinkGeneric 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2016
1	Chemotactic FactorsIBA 11/2016
1	ChemokinesIBA 11/2016
1	CXCR4 Receptors (CXCR4 Receptor)IBA 11/2016
1	Fluorescein (Funduscein)FDA LinkGeneric 05/2014
1	bleomycetinIBA 06/2013
1	Bevacizumab (Avastin)FDA Link 09/2012

Therapy/Procedure

8	Therapeutics 06/2022 - 01/2004
7	Decompression 05/2017 - 03/2010
4	Radiotherapy 05/2017 - 01/2008
4	Penetrating Keratoplasty 01/2015 - 01/2008
2	Laser In Situ Keratomileusis (LASIK) 01/2015 - 01/2003
1	Salvage Therapy 06/2022
1	Immunotherapy 01/2021
1	Neoadjuvant Therapy 12/2019
1	Artificial Eye (Artificial Eyes) 11/2018
1	Absorbable Gelatin Sponge 11/2018
1	Slit Lamp 01/2015
1	Cataract Extraction 08/2013
1	Intralesional Injections 06/2013